Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04366986 · ClinicalTrials.gov registry record
International Registry of Coronavirus (COVID-19) Exposure in Pregnancy
A clinical trial of COVID-19, sponsored by Pregistry.
- Completed
- Registry status
- 17,318
- Enrollment target
- 1
- Study location
NCT04366986: Completed study of COVID-19, sponsored by Pregistry.
NCT04366986 is a study of COVID-19 that has completed, run by Pregistry. The registered enrollment target is 17,318 participants, below the 38,407-participant average among 298 other COVID-19 trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04366986, a study of COVID-19, has completed, sponsored by Pregistry.
- COMPLETED
- Registry status
- 17,318 participants
- Enrollment target
- 1
- Study location
Study Summary
The International Registry of Coronavirus Exposure in Pregnancy (IRCEP) is a prospective cohort study of pregnant and recently pregnant women who have been tested for SARS-CoV-2 (regardless of the result) or have been clinically diagnosed with COVID-19 by a health care professional. Data from the IRCEP will be used to evaluate the impact of COVID-19 on pregnancy and birth outcomes.
Primary Outcome
Miscarriage (or spontaneous abortion), Elective termination, Stillbirth, Preterm delivery
Conditions Studied
Interventions
- OTHER Tested for SARS-CoV-2 (regardless of the result)
- OTHER Clinical diagnosis of COVID-19 by a health care professional
Study Locations (1)
California
- Pregistry - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,318 participants |
| Start Date | 2020-06-23 |
| Est. Completion | 2021-08-31 |
What the finished NCT04366986 record still lists
NCT04366986 is an observational study that tracks outcomes without assigning an intervention. Its 17,318 participants enrollment target places it among the larger protocols in the corpus, below the 38,407-participant average among 298 other COVID-19 trials with a reported enrollment target (55% lower).
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Tested for SARS-CoV-2 (regardless of the result) is the first listed.
NCT04366986 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04366986 about?
NCT04366986 is a clinical study titled "International Registry of Coronavirus (COVID-19) Exposure in Pregnancy". The International Registry of Coronavirus Exposure in Pregnancy (IRCEP) is a prospective cohort study of pregnant and recently pregnant women who have been tested for SARS-CoV-2 (regardless of the result) or have been clinically diagnosed with COVID-19 by a health care professional. Data from the IR...
What is the current status of trial NCT04366986?
This trial is currently completed. The enrollment target is 17,318 participants. The study started on 2020-06-23. Estimated completion is 2021-08-31.
What conditions does trial NCT04366986 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT04366986?
The interventions under investigation include: Tested for SARS-CoV-2 (regardless of the result) (OTHER), Clinical diagnosis of COVID-19 by a health care professional (OTHER).
Who is sponsoring clinical trial NCT04366986?
This trial is sponsored by Pregistry, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04366986 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04366986's enrollment target sits among peer trials
17,318 20th of 298 higher than 279 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06245187 · 17,198 participants
Get With the Guidelines Atrial Fibrillation Registry
- NCT06272110 · 17,500 participants
Promoting Equitable Access to Language Services in Health and Human Services
- NCT07290361 · 17,587 participants · NA
Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT)
- NCT06479447 · 17,000 participants · NA
Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI